These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25790721)

  • 1. Identification of metabolic markers in coronary artery disease using an untargeted LC-MS based metabolomic approach.
    Basak T; Varshney S; Hamid Z; Ghosh S; Seth S; Sengupta S
    J Proteomics; 2015 Sep; 127(Pt A):169-77. PubMed ID: 25790721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of the severity of coronary artery disease with patients' metabolic profile- rationale, design and baseline patient characteristics of the CorLipid trial.
    Karagiannidis E; Sofidis G; Papazoglou AS; Deda O; Panteris E; Moysidis DV; Stalikas N; Kartas A; Papadopoulos A; Stefanopoulos L; Karvounis H; Gika H; Theodoridis G; Sianos G
    BMC Cardiovasc Disord; 2021 Feb; 21(1):79. PubMed ID: 33557756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Untargeted metabolomics reveals altered branch chain amino acids, glucose and fat metabolism contributing to coronary artery disease among Indian diabetic patients.
    Adela R; Kasarla SS; Saquib N; Gupta SK; Bajpai S; Kumar Y; Banerjee SK
    Mol Omics; 2023 May; 19(4):321-329. PubMed ID: 36752683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Untargeted high-resolution plasma metabolomic profiling predicts outcomes in patients with coronary artery disease.
    Mehta A; Liu C; Nayak A; Tahhan AS; Ko YA; Dhindsa DS; Kim JH; Hayek SS; Sperling LS; Mehta PK; Sun YV; Uppal K; Jones DP; Quyyumi AA
    PLoS One; 2020; 15(8):e0237579. PubMed ID: 32810196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Metabolomic Characterization of Coronary Artery Diseases.
    Fan Y; Li Y; Chen Y; Zhao YJ; Liu LW; Li J; Wang SL; Alolga RN; Yin Y; Wang XM; Zhao DS; Shen JH; Meng FQ; Zhou X; Xu H; He GP; Lai MD; Li P; Zhu W; Qi LW
    J Am Coll Cardiol; 2016 Sep; 68(12):1281-93. PubMed ID: 27634119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untargeted Metabolomics Analysis of the Serum Metabolic Signature of Childhood Obesity.
    Szczerbinski L; Wojciechowska G; Olichwier A; Taylor MA; Puchta U; Konopka P; Paszko A; Citko A; Goscik J; Fiehn O; Fan S; Wasilewska A; Taranta-Janusz K; Kretowski A
    Nutrients; 2022 Jan; 14(1):. PubMed ID: 35011090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Coronary Artery Disease and Metabolic Syndrome: Usefulness of Serum Metabolomics Approach.
    Jing Z; Liu L; Shi Y; Du Q; Zhang D; Zuo L; Du S; Sun Z; Zhang X
    Front Endocrinol (Lausanne); 2021; 12():692893. PubMed ID: 34630321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale, comprehensive plasma metabolomic analyses reveal potential biomarkers for the diagnosis of early-stage coronary atherosclerosis.
    Sun M; Liu W; Jiang H; Wu X; Zhang S; Liu H
    Clin Chim Acta; 2024 Aug; 562():119832. PubMed ID: 38936535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
    J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-MS-based serum metabolomic analysis reveals dysregulation of phosphatidylcholines in esophageal squamous cell carcinoma.
    Mir SA; Rajagopalan P; Jain AP; Khan AA; Datta KK; Mohan SV; Lateef SS; Sahasrabuddhe N; Somani BL; Keshava Prasad TS; Chatterjee A; Veerendra Kumar KV; VijayaKumar M; Kumar RV; Gundimeda S; Pandey A; Gowda H
    J Proteomics; 2015 Sep; 127(Pt A):96-102. PubMed ID: 25982385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of the serum metabolite profile with a healthy Nordic diet and risk of coronary artery disease.
    Noerman S; Kokla M; Koistinen VM; Lehtonen M; Tuomainen TP; Brunius C; Virtanen JK; Hanhineva K
    Clin Nutr; 2021 May; 40(5):3250-3262. PubMed ID: 33190988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Untargeted metabolomic analysis of coronary artery disease patients with diastolic dysfunction show disturbed oxidative pathway.
    Fatima T; Hashmi S; Iqbal A; Siddiqui AJ; Sami SA; Basir N; Bokhari SS; Sharif H; Musharraf SG
    Metabolomics; 2019 Jun; 15(7):98. PubMed ID: 31236740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive transcriptomics and metabolomics analyses reveal that hyperhomocysteinemia is a high risk factor for coronary artery disease in a chinese obese population aged 40-65: a prospective cross-sectional study.
    Zhang CY; Xu RQ; Wang XQ; Sun LF; Mo P; Cai RJ; Lin XZ; Luo CF; Ou WC; Lu LJ; Zhong Y; Chen JY
    Cardiovasc Diabetol; 2023 Aug; 22(1):219. PubMed ID: 37620823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale Metabolomic Analysis Reveals Potential Biomarkers for Early Stage Coronary Atherosclerosis.
    Gao X; Ke C; Liu H; Liu W; Li K; Yu B; Sun M
    Sci Rep; 2017 Sep; 7(1):11817. PubMed ID: 28924163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics profiling and pathway analysis of human plasma and urine reveal further insights into the multifactorial nature of coronary artery disease.
    Amin AM; Mostafa H; Arif NH; Abdul Kader MAS; Kah Hay Y
    Clin Chim Acta; 2019 Jun; 493():112-122. PubMed ID: 30826371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
    Wu N; Wang W; Yi M; Cheng S; Wang D
    Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
    Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Metabolic Profiling of Inflammation Indicated Key Roles of Glycerophospholipid and Arginine Metabolism in Coronary Artery Disease.
    Zhu Q; Wu Y; Mai J; Guo G; Meng J; Fang X; Chen X; Liu C; Zhong S
    Front Immunol; 2022; 13():829425. PubMed ID: 35371012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics in posttraumatic stress disorder: Untargeted metabolomic analysis of plasma samples from Croatian war veterans.
    Konjevod M; Nedic Erjavec G; Nikolac Perkovic M; Sáiz J; Tudor L; Uzun S; Kozumplik O; Svob Strac D; Zarkovic N; Pivac N
    Free Radic Biol Med; 2021 Jan; 162():636-641. PubMed ID: 33249139
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.